AICPI
NBRV

ABG Innovation Capital Partners III’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

ABG Innovation Capital Partners III’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,834
Closed -$8K – 6
2022
Q2 		$8K Hold
1,834
– – 0.6% 5
2022
Q1 		$19K Hold
1,834
– – 1.3% 5
2021
Q4 		$27K Hold
1,834
– – 1.56% 6
2021
Q3 		$55K Hold
1,834
– – 2.29% 6
2021
Q2 		$62K Hold
1,834
– – 0.21% 7
2021
Q1 		$76K Hold
1,834
– – 0.04% 6
2020
Q4 		$111K Buy
+1,834
New +$199K 0.07% 7

Other funds holding NBRV

VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return